Optimize your hereditary angioedema (HAE) care management with the help of an allergist-immunologist, PCP, gastroenterologist ...

Hereditary angioedema (HAE) is a genetic condition that causes bouts of swelling in the tissue under your skin. The uncomfortable swelling can happen in many different parts of your body, including ...

Angioedema is deep tissue swelling that may occur due to various health conditions. Treating angioedema swelling depends on the cause. Angioedema may be acute or chronic, and acute symptoms may last ...

You can track and avoid triggers like certain foods or stress to help prevent hives. Seek medical care to confirm a hives diagnosis and identify the cause of your symptoms. You might take vitamin D3 ...

Staying active is an important component of a healthy lifestyle — it improves heart health, builds strength, and supports mental well-being. For people living with hereditary angioedema (HAE), a rare ...

Cyclosporine may be effective for improving urticaria activity but appeared to be among the most harmful with respect to increasing adverse events. Omalizumab and remibrutinib are among the most ...

Standard-dose omalizumab and remibrutinib are among the most effective systemic treatments for antihistamine-refractory chronic urticaria. “This first comprehensive analysis of all advanced treatment ...

Researchers are recruiting adults (≥18 years old) who suffer from cold urticaria, symptomatic dermographism, pressure hives, solar hives, heat hives, vibratory angioedema, exercise hives, contact ...

All compounds are either investigational or being studied for (a) new use(s). Efficacy and safety have not been established. There is no guarantee that they will become commercially available for the ...

In managing antihistamine-refractory chronic urticaria, omalizumab and remibrutinib stand out among the most effective treatments across multiple patient-important outcomes, followed by dupilumab, ...

Disclosure: Smiley has been a consultant for Novartis outside of the submitted work. Geng has received speaker/consultancy fees and/or research support from Sanofi, Regeneron, Genentech, Novartis, ...